Ipilimumab vs Sitagliptin

## Ipilimumab vs Sitagliptin: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Sitagliptin**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

**Sitagliptin**: DPP-4 inhibitor increasing incretin levels.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Sitagliptin — 12.4 hours.

## Chemical Properties

**Molecular Formula**: Ipilimumab — N/A; Sitagliptin — C16H15F6N5O.

**Molecular Weight**: Ipilimumab — N/A; Sitagliptin — 407.3140 g/mol.

**Type**: Ipilimumab — Antibody; Sitagliptin — Small molecule.